These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30877423)

  • 1. Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma.
    Jank BJ; Kadletz L; Schnöll J; Selzer E; Perisanidis C; Heiduschka G
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1487-1492. PubMed ID: 30877423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study.
    Gaudioso P; Borsetto D; Tirelli G; Tofanelli M; Cragnolini F; Menegaldo A; Fabbris C; Molteni G; Marchioni D; Nicolai P; Bossi P; Ciorba A; Pelucchi S; Bianchini C; Mauramati S; Benazzo M; Giacomarra V; Di Carlo R; Sethi M; Polesel J; Fussey J; Boscolo-Rizzo P
    Support Care Cancer; 2021 Aug; 29(8):4683-4691. PubMed ID: 33515105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
    He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
    Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pN status predicts outcomes in surgically treated pT1-pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study.
    Qian X; Sinikovic B; Schreiber F; Ochsenreither S; Klinghammer K; Wollenberg B; Kaufmann AM; Albers AE
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2787-2795. PubMed ID: 30159726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
    González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
    J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection.
    Zhou S; Yuan H; Wang J; Hu X; Liu F; Zhang Y; Jiang B; Zhang W
    Future Oncol; 2020 Apr; 16(10):559-571. PubMed ID: 32166977
    [No Abstract]   [Full Text] [Related]  

  • 9. Advanced Lung Cancer Inflammation index: a prognostic score in patients with metastatic non-small cell lung cancer.
    Bacha S; Sghaier A; Habibech S; Cheikhrouhou S; Racil H; Chaouch N; Chabbou A; Megdiche ML
    Tunis Med; 2017 Novembre; 95(11):976-981. PubMed ID: 29877556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the accuracy of clinical prediction of survival and palliative prognostic index for patients with head and neck squamous cell carcinoma in the end-of-life setting.
    Kishino T; Monden N; Akisada N; Hayashi Y; Nakamura M; Hashimoto K; Miyashita T; Mori T; Hoshikawa H
    Auris Nasus Larynx; 2022 Feb; 49(1):133-140. PubMed ID: 34226098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma.
    Baumeister P; Canis M; Reiter M
    PLoS One; 2018; 13(10):e0205712. PubMed ID: 30347001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
    Liu JC; Kaplon A; Blackman E; Miyamoto C; Savior D; Ragin C
    Laryngoscope; 2020 Apr; 130(4):946-950. PubMed ID: 31095740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
    Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
    Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
    Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
    Kim EY; Kim N; Kim YS; Seo JY; Park I; Ahn HK; Jeong YM; Kim JH
    PLoS One; 2016; 11(10):e0164056. PubMed ID: 27706243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
    Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
    Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.